• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients.找到合适的契合度:肿瘤内科门诊患者在治疗决策中偏好的参与度与感知到的参与度之间的趋同。
Health Sci Rep. 2018 Nov 6;2(1):e101. doi: 10.1002/hsr2.101. eCollection 2019 Jan.
2
Preferences for and experiences of family involvement in cancer treatment decision-making: patient-caregiver dyads study.患者-照顾者对癌症治疗决策中家庭参与的偏好和体验:患者-照顾者对癌症治疗决策中家庭参与的偏好和体验:患者-照顾者对癌症治疗决策中家庭参与的偏好和体验研究。
Psychooncology. 2013 Nov;22(11):2624-31. doi: 10.1002/pon.3339. Epub 2013 Jul 24.
3
Preferred and perceived participation roles of oncological patients in medical decision-making: Results of a survey among users of the German Cancer Information Service.肿瘤患者在医疗决策中偏好和感知的参与角色:德国癌症信息服务用户调查的结果。
Z Evid Fortbild Qual Gesundhwes. 2022 Aug;172:40-48. doi: 10.1016/j.zefq.2022.04.026. Epub 2022 Jun 24.
4
Veterans' decision-making preferences and perceived involvement in care for chronic heart failure.退伍军人对慢性心力衰竭护理的决策偏好及感知参与度
Heart Lung. 2008 Nov-Dec;37(6):440-8. doi: 10.1016/j.hrtlng.2008.02.003. Epub 2008 Sep 30.
5
Exploring patterns in psychiatric outpatients' preferences for involvement in decision-making: a latent class analysis approach.探讨精神科门诊患者参与决策偏好模式:潜在类别分析方法。
BMC Psychiatry. 2021 Mar 6;21(1):133. doi: 10.1186/s12888-021-03137-x.
6
Not asking cancer patients about their preferences does make a difference. A cross-sectional study examining cancer patients' preferred and perceived role in decision-making regarding their last important cancer treatment.不询问癌症患者的偏好确实会产生影响。一项横断面研究调查了癌症患者在其最后一次重要癌症治疗决策中偏好的和感知到的角色。
Eur J Cancer Care (Engl). 2018 Sep;27(5):e12871. doi: 10.1111/ecc.12871. Epub 2018 Jun 14.
7
Cancer patients' preferred and perceived level of involvement in treatment decision-making: an epidemiological study.癌症患者对治疗决策参与的偏好和感知水平:一项流行病学研究。
Acta Oncol. 2020 Aug;59(8):967-974. doi: 10.1080/0284186X.2020.1762926. Epub 2020 May 19.
8
Perceived problems with involvement in decision making about breast cancer treatment and care: A cross-sectional study.参与乳腺癌治疗和护理决策中感知到的问题:一项横断面研究。
Patient Educ Couns. 2021 Mar;104(3):505-511. doi: 10.1016/j.pec.2020.08.044. Epub 2020 Sep 2.
9
Patients' preferred and retrospectively perceived levels of involvement during decision-making regarding carpal tunnel release.患者在腕管松解术决策中对参与度的偏好和回顾性感知。
J Bone Joint Surg Am. 2011 Aug 17;93(16):1527-33. doi: 10.2106/JBJS.J.00951.
10
Treatment decision-making in the medical encounter: comparing the attitudes of French surgeons and their patients in breast cancer care.医疗过程中的治疗决策:比较法国外科医生及其乳腺癌患者的态度
Patient Educ Couns. 2014 Feb;94(2):230-7. doi: 10.1016/j.pec.2013.07.011. Epub 2013 Dec 8.

引用本文的文献

1
Patients' preferred and perceived level of involvement in decision making for cancer treatment: A systematic review.患者对癌症治疗决策的偏好和感知参与度:系统评价。
Psychooncology. 2021 Oct;30(10):1663-1679. doi: 10.1002/pon.5750. Epub 2021 Jun 28.
2
Assessing and reporting patient participation by means of patient preferences and experiences.评估和报告患者参与情况,方法是了解患者的偏好和体验。
BMC Health Serv Res. 2020 Jul 29;20(1):702. doi: 10.1186/s12913-020-05574-y.

本文引用的文献

1
Not asking cancer patients about their preferences does make a difference. A cross-sectional study examining cancer patients' preferred and perceived role in decision-making regarding their last important cancer treatment.不询问癌症患者的偏好确实会产生影响。一项横断面研究调查了癌症患者在其最后一次重要癌症治疗决策中偏好的和感知到的角色。
Eur J Cancer Care (Engl). 2018 Sep;27(5):e12871. doi: 10.1111/ecc.12871. Epub 2018 Jun 14.
2
Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.年轻和老年乳腺癌患者对早期乳腺癌治疗决策的偏好和感知参与:一项前瞻性研究。
Clin Breast Cancer. 2018 Apr;18(2):e245-e253. doi: 10.1016/j.clbc.2017.11.013. Epub 2017 Nov 28.
3
Incongruence in treatment decision making is associated with lower health-related quality of life among prostate cancer survivors: results from the PiCTure study.治疗决策不一致与前列腺癌幸存者的健康相关生活质量较低有关:来自 PiCTure 研究的结果。
Support Care Cancer. 2018 May;26(5):1645-1654. doi: 10.1007/s00520-017-3994-z. Epub 2017 Dec 8.
4
Preferences and actual chemotherapy decision-making in the greater plains collaborative breast cancer study.大平原地区乳腺癌协作研究中的偏好与实际化疗决策
Acta Oncol. 2017 Dec;56(12):1690-1697. doi: 10.1080/0284186X.2017.1374555. Epub 2017 Sep 13.
5
Regret about surgical decisions among early-stage breast cancer patients: Effects of the congruence between patients' preferred and actual decision-making roles.早期乳腺癌患者对手术决策的后悔:患者偏好的和实际决策角色之间一致性的影响。
Psychooncology. 2018 Feb;27(2):508-514. doi: 10.1002/pon.4522. Epub 2017 Sep 11.
6
Understanding older women's decision making and coping in the context of breast cancer treatment.了解老年女性在乳腺癌治疗背景下的决策与应对方式。
BMC Med Inform Decis Mak. 2015 Jun 10;15:45. doi: 10.1186/s12911-015-0167-1.
7
Shared decision making in patients at risk of cancer: the role of domain and numeracy.癌症风险患者的共同决策:领域和数字能力的作用。
Health Expect. 2015 Dec;18(6):2799-810. doi: 10.1111/hex.12257. Epub 2014 Sep 4.
8
Congruence between patients' preferred and perceived participation in medical decision-making: a review of the literature.患者对参与医疗决策的偏好与感知的一致性:文献综述。
BMC Med Inform Decis Mak. 2014 Apr 3;14:25. doi: 10.1186/1472-6947-14-25.
9
Supporting shared decisions when clinical evidence is low.支持临床证据不足时的共同决策。
Med Care Res Rev. 2013 Feb;70(1 Suppl):113S-128S. doi: 10.1177/1077558712458456. Epub 2012 Nov 1.
10
Information-seeking experiences and decision-making roles of Japanese women with breast cancer.日本乳腺癌女性的信息寻求经历与决策角色。
Fukuoka Igaku Zasshi. 2012 Jun;103(6):120-30.

找到合适的契合度:肿瘤内科门诊患者在治疗决策中偏好的参与度与感知到的参与度之间的趋同。

Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients.

作者信息

Mansfield Elise, Bryant Jamie, Carey Mariko, Turon Heidi, Henskens Frans, Grady Alice

机构信息

Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine University of Newcastle Callaghan Australia.

Priority Research Centre for Health Behaviour University of Newcastle Callaghan Australia.

出版信息

Health Sci Rep. 2018 Nov 6;2(1):e101. doi: 10.1002/hsr2.101. eCollection 2019 Jan.

DOI:10.1002/hsr2.101
PMID:30697595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6346985/
Abstract

BACKGROUND AND AIMS

While cancer patients' preferences for their level of involvement in treatment decision making (TDM) vary, previous research indicates a large proportion of patients are not experiencing TDM that meets their preferences. Evidence is needed to identify the characteristics of cancer patients who are less likely to report experiencing their preferred level of involvement in TDM, so that appropriate decision-making support can be provided to them. We examined in a sample of medical oncology outpatients (1) the level of agreement between preferred and perceived involvement in TDM and (2) demographic, psychological, disease, and treatment characteristics associated with having unmet preferences for involvement in TDM.

METHODS AND RESULTS

Cancer patients from three medical oncology treatment centers in Australia completed surveys assessing demographic, disease and treatment variables, psychological distress, and preferred and perceived involvement in TDM. Data were collected between February 2013 and December 2014. Factors associated with having unmet TDM preferences were examined using logistic regression. There were 355 patients included in the analysis (75% response rate). The mean age (±SD) of the participants was 61 (±12), and 45% were male. Overall, 60% of participants reported that their preferences for involvement in TDM were met. No demographic, psychological, disease, or treatment characteristics were significantly associated with an increased probability of not having TDM preferences met.

CONCLUSIONS

In line with previous research, a large proportion (40%) of patients reported TDM experiences that were not in alignment with their preferences. Future research should explore additional characteristics that are associated with a lower likelihood of having TDM preferences met.

摘要

背景与目的

虽然癌症患者对参与治疗决策(TDM)程度的偏好各不相同,但先前的研究表明,很大一部分患者并未经历符合其偏好的TDM。需要证据来确定不太可能报告经历其偏好的TDM参与程度的癌症患者的特征,以便为他们提供适当的决策支持。我们在一组医学肿瘤门诊患者样本中研究了以下两点:(1)TDM中偏好的与感知到的参与程度之间的一致程度;(2)与TDM参与偏好未得到满足相关的人口统计学、心理、疾病和治疗特征。

方法与结果

来自澳大利亚三个医学肿瘤治疗中心的癌症患者完成了调查,评估人口统计学、疾病和治疗变量、心理困扰以及TDM中偏好的与感知到的参与程度。数据收集于2013年2月至2014年12月之间。使用逻辑回归分析与TDM偏好未得到满足相关的因素。分析纳入了355名患者(回复率为75%)。参与者的平均年龄(±标准差)为61(±12)岁,45%为男性。总体而言,60%的参与者报告他们对TDM参与的偏好得到了满足。没有人口统计学、心理、疾病或治疗特征与TDM偏好未得到满足的可能性增加显著相关。

结论

与先前的研究一致,很大一部分(40%)患者报告的TDM经历与其偏好不一致。未来的研究应探索与TDM偏好得到满足的可能性较低相关的其他特征。